I
iXbio focuses on developing novel small molecule therapeutics for oncology and inflammatory diseases. The company utilizes proprietary screening platforms to identify and optimize drug candidates with high selectivity and potency. Their pipeline aims to address unmet medical needs through targeted molecular intervention.
Updated 2 months ago
Funding
Funding not disclosed
Funding rounds are not available yet.
Founders
Founder details are not available yet.
Product
Features
- iXbio focuses on developing novel small molecule therapeutics for oncology and inflammatory diseases. The company utilizes proprietary screening platforms to identify and optimize drug candidates with high selectivity and potency. Their pipeline aims to address unmet medical needs through targeted molecular intervention.